Nabriva Therapeutics (NBRVF) Q2 2018 Earnings

9AugExpected
Q3 2017
Q4 2017
Q1 2018
Q2 2018
-0.79
-0.65
-0.5
-0.36

Details

Expected EPS
-0.48
Actual EPS
-0.44
Surprise EPS
0.04
Surprise Percent
+8.33%

Description

Nabriva Therapeutics (NBRVF) has reported earnings of -0.44 per share for Q2 2018.

0 Comments

Share your thoughts